Oxonic Acid -13C2,15N3 Potassium Salt Hydrate

• Catalog No.: O870062
• M. F.: C4H4KN3O5
• M. W.: 218.15549637
• Storage: -20°C Freezer

SYNONYMS

• IUPAC name: potassium 4,6-dioxo-1,4,5,6-tetrahydro(4,6-^1^3C₂,1,3,5-^1^5N₃)-1,3,5-triazine-2-carboxylate hydrate
• IUPAC Traditional name: potassium 4,6-dioxo-1,5-dihydro(4,6-^1^3C₂,1,3,5-^1^5N₃)-1,3,5-triazine-2-carboxylate hydrate
• Synonyms: Oteracil Potassium Salt-13C2,15N3 Hydrate; Triazine-2,4-dione-6-carboxylic Acid-Potassium Salt-13C2,15N3 Hydrate; 1,4,5,6-Tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylic Acid Potassium Salt-13C2,15N3 Hydrate; 5-Azaorotic Acid Potassium Salt-13C2,15N3 Hydrate

PROPERTIES

• Apperance: Beige Solid
• Melting Point: >250°C (dec.)
• Solubility: Water
• Storage Condition: -20°C Freezer

DETAILS

Description (English)

Antitumor effect potentiator and antitumor agent.

REFERENCES

• Chelbova, et al.: Biochem. Pharmacol., 19, 1785 (1970)
• Collins, J., et al.: Clin. Pharmacol. Ther., 28, 235 (1970)
• Hoff, P., et al.: Anticancer Drugs, 9, 479 (1970)
• Backus, H., et al.: Oncol. Res., 12, 231(1970)
• Peters, G., et al.: J. Clin. Oncol., 19